0001104659-18-013697.txt : 20180228
0001104659-18-013697.hdr.sgml : 20180228
20180228213251
ACCESSION NUMBER: 0001104659-18-013697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180228
DATE AS OF CHANGE: 20180228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bergstein Ivan
CENTRAL INDEX KEY: 0001554767
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35619
FILM NUMBER: 18654454
MAIL ADDRESS:
STREET 1: C/O STEMLINE THERAPEUTICS, INC.
STREET 2: 750 LEXINGTON AVENUE, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001264587
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450522567
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: ELEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-502-2311
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
a4.xml
4
X0306
4
2018-02-26
0
0001264587
STEMLINE THERAPEUTICS INC
STML
0001554767
Bergstein Ivan
C/O STEMLINE THERAPEUTICS, INC.
750 LEXINGTON AVENUE, ELEVENTH FLOOR
NEW YORK
NY
10022
1
1
0
0
Chief Executive Officer
Common Stock
2018-02-26
4
S
0
10776
17.61
D
2070784
D
Common Stock
2018-02-27
4
S
0
13407
17.26
D
2057377
D
In connection with the vesting of 44,521 shares on February 24, 2018, a total of 24,183 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
Reflects the weighted average sale price. The range of prices for such transaction is $17.60 to $17.80. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 2,070,784 shares, 380,456 are restricted stock.
Reflects the weighted average sale price. The range of prices for such transaction is $17.00 to $17.50. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Of the 2,057,377 shares, 380,456 are restricted stock.
/s/ Ivan Bergstein
2018-02-28